Cooper, Z. A., Reuben, A., Spencer, C. N., Prieto, P. A., Austin-Breneman, J. L., Jiang, H., . . . Parra, E. R. (2016). Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma. OncoImmunology, 5(3), 1. https://doi.org/10.1080/2162402X.2015.1136044
Chicago Style (17th ed.) CitationCooper, Zachary A., et al. "Distinct Clinical Patterns and Immune Infiltrates Are Observed at Time of Progression on Targeted Therapy Versus Immune Checkpoint Blockade for Melanoma." OncoImmunology 5, no. 3 (2016): 1. https://doi.org/10.1080/2162402X.2015.1136044.
MLA (9th ed.) CitationCooper, Zachary A., et al. "Distinct Clinical Patterns and Immune Infiltrates Are Observed at Time of Progression on Targeted Therapy Versus Immune Checkpoint Blockade for Melanoma." OncoImmunology, vol. 5, no. 3, 2016, p. 1, https://doi.org/10.1080/2162402X.2015.1136044.